ReviewNeuro-oncology advances

Targeting the Siglec/sialic-acid axis in glioblastoma: Glycome-mediated immune evasion and emerging therapeutic platforms.

David Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.